Choose a country below to begin
- FRP- Reliance (Verification)
- FRP- Reliance (Abbreviated Review)
- Priority Pathway
- Orphan Drug Route
- Conditional Registration for Pharmaceutical Products During Disaster
- Conditional Registration for New Chemical Entities and Biologics in Malaysia
- Malaysia-Japan Cooperation on Simplifying Drug Review Procedure
- HSA-NPRA Generic Medicines Work Sharing Initiative
- FRP- Reliance (Abbreviated Review)
- Priority Pathway
- Orphan Drug Route
- Conditional Registration for Pharmaceutical Products During Disaster
- Conditional Registration for New Chemical Entities and Biologics in Malaysia
- Malaysia-Japan Cooperation on Simplifying Drug Review Procedure
- HSA-NPRA Generic Medicines Work Sharing Initiative
- Collaborative Review Process (Accelerated registration of WHO-prequalified pharmaceutical products and vaccines
- Orphan Drug Route
- Registration of Drug Products under Emergency Use for the Coronavirus Disease 2019 (COVID-19) (INITIAL-DEU)
- Facilitated Review Pathway (Verification Review)
- Facilitated Review Pathway (Abridged Review)
- Emergency Use Authorization for Drugs & Vaccines for COVID-19
- Orphan Drug Route
- Registration of Drug Products under Emergency Use for the Coronavirus Disease 2019 (COVID-19) (INITIAL-DEU)
- Facilitated Review Pathway (Verification Review)
- Facilitated Review Pathway (Abridged Review)
- Emergency Use Authorization for Drugs & Vaccines for COVID-19